Detectable concentrations of Fas ligand in cerebrospinal fluid after severe head injury

被引:46
作者
Ertel, W
Keel, M
Stocker, R
Imhof, HG
Leist, M
Steckholzer, U
Tanaka, M
Trentz, O
Nagata, S
机构
[1] UNIV ZURICH HOSP, DEPT NEUROSURG, CH-8091 ZURICH, SWITZERLAND
[2] UNIV KONSTANZ, FAC BIOL, DEPT TOXICOL, D-7750 CONSTANCE, GERMANY
[3] OSAKA UNIV, SCH MED, DEPT GENET, OSAKA, JAPAN
关键词
Fas antigen; Fas ligand; apoptosis; head injury; brain oedema; cerebrospinal fluid;
D O I
10.1016/S0165-5728(97)00139-2
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
When the cell surface molecule Fas is triggered by its agonist Fas ligand the result is apoptosis of these cells and tissue destruction. To elucidate the pathophysiological relevance of Fas ligand in patients with cerebral oedema caused by trauma, we examined its concentrations in cerebrospinal fluid in 18 patients using specific ELISA. Serum and cerebrospinal fluid from healthy people and injured patients without head trauma did not contain detectable Fas ligand. In contrast, cerebrospinal fluid from patients with severe brain injury contained high concentrations of Fas ligand without detectable concentrations in serum. Soluble Fas ligand concentrations in cerebrospinal fluid correlated significantly with severity of brain injury. The Fas-Fas ligand-system may have a pivotal role in causing oedema and local tissue destruction in the brain after severe head injury. (C) 1997 Elsevier Science B.V.
引用
收藏
页码:93 / 96
页数:4
相关论文
共 21 条
[1]   PROTECTION FROM FAS-MEDIATED APOPTOSIS BY A SOLUBLE FORM OF THE FAS MOLECULE [J].
CHENG, JH ;
ZHOU, T ;
LIU, CD ;
SHAPIRO, JP ;
BRAUER, MJ ;
KIEFER, MC ;
BARR, PJ ;
MOUNTZ, JD .
SCIENCE, 1994, 263 (5154) :1759-1762
[2]   AUTOCRINE T-CELL SUICIDE MEDIATED BY APO-1/(FAS/CD95) [J].
DHEIN, J ;
WALCZAK, H ;
BAUMLER, C ;
DEBATIN, KM ;
KRAMMER, PH .
NATURE, 1995, 373 (6513) :438-441
[3]   Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain [J].
Dowling, P ;
Shang, GF ;
Raval, S ;
Menonna, J ;
Cook, S ;
Husar, W .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (04) :1513-1518
[4]   NERVOUS-TISSUE AS AN IMMUNE COMPARTMENT - THE DIALECT OF THE IMMUNE-RESPONSE IN THE CNS [J].
FABRY, Z ;
RAINE, CS ;
HART, MN .
IMMUNOLOGY TODAY, 1994, 15 (05) :218-224
[5]   Fas and Fas ligand in embryos and adult mice: Ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover [J].
French, LE ;
Hahne, M ;
Viard, I ;
Radlgruber, G ;
Zanone, R ;
Becker, K ;
Muller, C ;
Tschopp, J .
JOURNAL OF CELL BIOLOGY, 1996, 133 (02) :335-343
[6]   INVOLVEMENT OF THE CD95 (APO-1/FAS) RECEPTOR AND LIGAND IN LIVER-DAMAGE [J].
GALLE, PR ;
HOFMANN, WJ ;
WALCZAK, H ;
SCHALLER, H ;
OTTO, G ;
STREMMEL, W ;
KRAMMER, PH ;
RUNKELL, L .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (05) :1223-1230
[7]   COMPARISON OF MORTALITY, MORBIDITY, AND SEVERITY OF 59,713 HEAD-INJURED PATIENTS WITH 114,447 PATIENTS WITH EXTRACRANIAL INJURIES [J].
GENNARELLI, TA ;
CHAMPION, HR ;
COPES, WS ;
SACCO, WJ .
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 1994, 37 (06) :962-968
[8]   ANTI-FAS MONOCLONAL-ANTIBODY IS CYTOCIDAL TO HUMAN IMMUNODEFICIENCY VIRUS-INFECTED CELLS WITHOUT AUGMENTING VIRAL REPLICATION [J].
KOBAYASHI, N ;
HAMAMOTO, Y ;
YAMAMOTO, N ;
ISHII, A ;
YONEHARA, M ;
YONEHARA, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (24) :9620-9624
[9]   Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice [J].
Lau, HT ;
Yu, M ;
Fontana, A ;
Stoeckert, CJ .
SCIENCE, 1996, 273 (5271) :109-112
[10]   FAS ANTIGEN MESSENGER-RNA INDUCTION IN POSTISCHEMIC MURINE BRAIN [J].
MATSUYAMA, T ;
HATA, R ;
TAGAYA, M ;
YAMAMOTO, Y ;
NAKAJIMA, T ;
FURUYAMA, J ;
WANAKA, A ;
SUGITA, M .
BRAIN RESEARCH, 1994, 657 (1-2) :342-346